Lumiere

bevacizumab · Laboratorio Elea Phoenix S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lumiere, covering 2020-10-28 to 2020-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD) [Phase 3]

See pricing